Pharmafile Logo
Pharmafocus logo
Advanced Search

Sutent

Showing 4 posts of 19 posts found.

Pfizer halts Sutent colon cancer trial

July 2, 2009
Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …

News

Pfizer halts Sutent head-to-head trial

April 6, 2009
Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a late-stage breast cancer trial between Sutent and Roche's Xeloda, after the study failed to show significant …

News

NICE recommends Pfizer’s Sutent

March 26, 2009
Research and Development NICE, Pfizer, Sutent

NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …

News

Pfizer switches agencies in time for Sutent’s UK launch

August 18, 2006
Medical Communications Reynolds-Mackenzie, Sutent

 Pfizer has enlisted PR agency Reynolds-Mackenzie to support the UK launch and subsequent development of its potential blockbuster kidney cancer …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026